DLBCL UNCLASSIFIABLE
Clinical trials for DLBCL UNCLASSIFIABLE explained in plain language.
Never miss a new study
Get alerted when new DLBCL UNCLASSIFIABLE trials appear
Sign up with your email to follow new studies for DLBCL UNCLASSIFIABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a new drug called BGB-16673 for people with certain blood cancers (B-cell malignancies) that have come back or not responded to treatment. The goal is to find the best dose and see if it is safe and shrinks tumors. About 146 Chinese adults will take part in this …
Matched conditions: DLBCL UNCLASSIFIABLE
Phase: PHASE1, PHASE2 • Sponsor: BeiGene • Aim: Disease control
Last updated May 17, 2026 02:04 UTC
-
New combo therapy aims to boost CAR T-Cell success in tough blood cancers
Disease control Recruiting nowThis early-phase study tests a two-step approach for people with relapsed or hard-to-treat B-cell acute lymphoblastic leukemia or diffuse large B-cell lymphoma. First, patients receive a radioactive antibody (131-I apamistamab) to prepare the body, followed by CAR T-cell therapy …
Matched conditions: DLBCL UNCLASSIFIABLE
Phase: EARLY_PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 01:59 UTC